1. AIR-Net: A novel multi-task learning method with auxiliary image reconstruction for predicting EGFR mutation status on CT images of NSCLC patients
    Dongqi Gui et al, 2022, Computers in Biology and Medicine CrossRef
  2. Traditional Chinese Medicine Syndromes are Associated with Driver Gene Mutations and Clinical Characteristics in Patients with Lung Adenocarcinoma
    Jili Yang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  3. Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report
    Aurélie Louvet et al, 2023, Frontiers in Oncology CrossRef
  4. Prognostic Impact of EBUS TBNA for Lung Adenocarcinoma Patients with Postoperative Recurrences
    Ying-Yi Chen et al, 2022, Diagnostics CrossRef
  5. Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway
    Jiali Wang et al, 2024, Pharmaceutical Biology CrossRef
  6. Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction
    Federico Pio Fabrizio et al, 2023, Frontiers in Oncology CrossRef
  7. Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
    Roberto Bei et al, 2022, Journal of Translational Medicine CrossRef
  8. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
    Ping-Chih Hsu et al, 2023, Targeted Oncology CrossRef
  9. PLGA-PEI nanobubbles carrying PDLIM5 siRNA inhibit EGFR-TKI-resistant NSCLC cell migration and invasion ability using UTND technology
    Hui Li et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  10. Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer
    Jiajian Shi et al, 2022, Oncologie CrossRef
  11. Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma
    Ying-Yi Chen et al, 2023, World Journal of Surgical Oncology CrossRef
  12. Deep learning for preoperative prediction of the EGFR mutation and subtypes based on the MRI image of spinal metastasis from primary NSCLC
    Tao Jiang et al, 2023, Biomedical Signal Processing and Control CrossRef
  13. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
    Shant Qinxiang Sin et al, 2023, Cancer and Metastasis Reviews CrossRef